SARS-CoV-2 Antibodies in Children with Chronic Disease from a Pediatric Gastroenterology Outpatient Clinic |
Kaya, Gulay
(Department of Pediatrics, Karadeniz Technical University Faculty of Medicine)
Issi, Fatma (Department of Pediatric Gastroenterology, Hepatology and Nutrition, Karadeniz Technical University Faculty of Medicine) Guven, Burcu (Department of Pediatric Gastroenterology, Hepatology and Nutrition, Karadeniz Technical University Faculty of Medicine) Ozkaya, Esra (Department of Microbiology, Karadeniz Technical University Faculty of Medicine) Buruk, Celal Kurtulus (Department of Microbiology, Karadeniz Technical University Faculty of Medicine) Cakir, Murat (Department of Pediatric Gastroenterology, Hepatology and Nutrition, Karadeniz Technical University Faculty of Medicine) |
1 | Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-42. DOI |
2 | Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020;109:1088-95. DOI |
3 | Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and metaanalysis. Gastroenterology 2020;159:81-95. DOI |
4 | Assa A, Benninga MA, Borrelli O, Broekaert I, de Carpi JM, Saccomani MD, et al.; Gastrointestinal Committee of ESPGHAN. Gastrointestinal perspective of coronavirus disease 2019 in children-an updated review. J Pediatr Gastroenterol Nutr 2021;73:299-305. DOI |
5 | Yuksel M, Akturk H, Mizikoglu O, Toroslu E, Arikan C. A single-center report of COVID-19 disease course and management in liver transplanted pediatric patients. Pediatr Transplant 2021;25:e14061. |
6 | Akobeng AK, Grafton-Clarke C, Abdelgadir I, Twum-Barimah E, Gordon M. Gastrointestinal manifestations of COVID-19 in children: a systematic review and meta-analysis. Frontline Gastroenterol 2020;12:332-7 |
7 | Roche Diagnostics GmbH. Elecsys® Anti-SARS-CoV-2 S assay [Internet]. Burgess Hill: Roche Diagnostics GmbH; 2022 [cited 2022 May 4]. Available from: https://diagnostics.Roche.com/gb/en/products/params/elecsys-anti-sars-cov-2-s.html |
8 | Di Giorgio A, Hartleif S, Warner S, Kelly D. COVID-19 in children with liver disease. Front Pediatr 2021;9:616381. |
9 | Corrias A, Cortes GM, Bardanzellu F, Melis A, Fanos V, Marcialis MA. Risk, course, and effect of SARS-CoV-2 infection in children and adults with chronic inflammatory bowel diseases. Children (Basel) 2021;8:753. |
10 | Cakir M, Guven B, Issi F, Ozkaya E. New-onset celiac disease in children during COVID-19 pandemic. Acta Paediatr 2022;111:383-8. DOI |
11 | Colmenero J, Rodriguez-Peralvarez M, Salcedo M, Arias-Milla A, Munoz-Serrano A, Graus J, et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol 2021;74:148-55. |
12 | Tullie L, Ford K, Bisharat M, Watson T, Thakkar H, Mullassery D, et al. Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children. Lancet Child Adolesc Health 2020;4:e19-20. DOI |
13 | Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, et al. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. DOI |
14 | Tannuri U, Tannuri ACA, Cordon MNA, Miyatani HT. Low incidence of COVID-19 in children and adolescent post-liver transplant at a Latin American reference center. Clinics (Sao Paulo) 2020;75:e1986. |
15 | Buescher G, Sebode M, Marjot T, Webb GJ, Moon AM, Barnes E, et al. SARS-CoV-2 in pediatric liver transplant recipients: the European experience. J Pediatr Gastroenterol Nutr 2022;74:e41-2. DOI |
16 | Sansotta N, Norsa L, Zuin G, Panceri R, Dilillo D, Pozzi E, et al. Children with inflammatory bowel disease in the COVID-19 main endemic focus: the Lombardy experience. Front Pediatr 2021;9:607285. |
17 | Romanelli A, Mascolo S. Immunosuppression drug-related and clinical manifestation of Coronavirus disease 2019: a therapeutical hypothesis. Am J Transplant 2020;20:1947-8. DOI |
18 | Nicastro E, Ebel NH, Kehar M, Czubkowski P, Ng VL, Michaels MG, et al. The impact of severe acute respiratory syndrome coronavirus type 2 on children with liver diseases: a joint European Society for Pediatric Gastroenterology, Hepatology and Nutrition and Society of Pediatric Liver Transplantation position paper. J Pediatr Gastroenterol Nutr 2022;74:159-70. DOI |
19 | Kehar M, Ebel NH, Ng VL, Baquero JER, Leung DH, Slowik V, et al. Severe Acute respiratory syndrome coronavirus-2 infection in children with liver transplant and native liver disease: an international observational registry study. J Pediatr Gastroenterol Nutr 2021;72:807-14. DOI |
20 | Di Giorgio A, Nicastro E, Arnaboldi S, Montini O, Di Stasio F, D'Antiga L, et al. "Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study". Clin Res Hepatol Gastroenterol 2021;45:101610. |
21 | Sin P, Diaz LA, Martinez M, Vizcaya C, D'Agostino D, Gana JC. Acute liver injury among pediatric liver transplantation recipients with coronavirus disease 2019: an international collaborative study. J Pediatr Gastroenterol Nutr 2021;73:391-4. Erratum in: J Pediatr Gastroenterol Nutr 2022;74:171. |
22 | Turner D, Huang Y, Martin-de-Carpi J, Aloi M, Focht G, Kang B, et al. Paediatric IBD Porto group of ESPGHAN. Corona virus disease 2019 and paediatric inflammatory bowel diseases: global experience and provisional guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2020;70:727-33. DOI |
![]() |